Biopsy Clinical Trials

2 recruiting

Biopsy Trials at a Glance

66 actively recruiting trials for biopsy are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 27 trials, with the heaviest enrollment activity in Tianjin, Paris, and Houston. Lead sponsors running biopsy studies include Tianjin Medical University Second Hospital, China-Japan Friendship Hospital, and Alfred Health.

Browse biopsy trials by phase

Treatments under study

About Biopsy Clinical Trials

Looking for clinical trials for Biopsy? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Biopsy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Biopsy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 66 trials

Recruiting
Not Applicable

Routine Probe Compression After Transrectal Prostate Biopsy(RPCAB) to Reduce Bleeding and Infectious Complications : A Randomized Controlled Trial

Prostate BiopsyPost Biopsy Bleeding
Veterans Health Service Medical Center, Seoul, Korea324 enrolled1 locationNCT07550985
Recruiting

Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity

Sentinel Lymph Node Biopsy (SLNB)Early Stage Ovarian Tumors
Faculty of Medicine of Tunis30 enrolled1 locationNCT07508306
Recruiting
Phase 4

Pipelle vs the Curved Aspirator Device

Endometrial Biopsy
Maimonides Medical Center124 enrolled1 locationNCT07513493
Recruiting

Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery

Breast CancerSentinel Lymph Node Biopsy (SLNB)Axillary Lymph Nodes Dissection+1 more
University Hospitals of Derby and Burton NHS Foundation Trust200 enrolled12 locationsNCT07085442
Recruiting
Not Applicable

Robotic-Assisted Versus Conventional Bronchoscopy for Cryobiopsy in the Diagnosis of Interstitial Lung Disease

Lung BiopsyInterstitial Lung Disease (ILD)
University of Zurich30 enrolled2 locationsNCT07500818
Recruiting
Phase 2

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

Bladder CancerImmunotherapyLiquid Biopsy
Tianjin Medical University Second Hospital53 enrolled1 locationNCT07475403
Recruiting
Not Applicable

The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial

Abnormal Uterine BleedingPain in Endometrial Biopsy
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization120 enrolled1 locationNCT07496905
Recruiting
Not Applicable

Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer

Bladder CancerLiquid BiopsyCystoscopy
Tianjin Medical University Second Hospital360 enrolled2 locationsNCT07180212
Recruiting

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

Breast Cancer, Liquid Biopsy, Early Detection
Syantra Inc.2,000 enrolled4 locationsNCT07219277
Recruiting
Not Applicable

Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Levels, Development of Complications, and Hospital Readmission in Transrectal Ultrasound-Guided Prostate Biopsy

TRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSY
Tarsus University84 enrolled2 locationsNCT07462390
Recruiting

Non-invasive Evaluation of Graft Condition in Adult Patients With Kidney Transplant Using Ultrasound Localization Microscopy and Multispectral Optoacoustic Tomography

Kidney TransplantKidney Biopsy
University of Erlangen-Nürnberg Medical School10 enrolled1 locationNCT06472947
Recruiting

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

Bladder CancerLiquid Biopsy
Tianjin Medical University Second Hospital60 enrolled2 locationsNCT07130578
Recruiting
Not Applicable

Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

Bladder CancerLiquid BiopsyRepeat Transurethral Resection of Bladder Tumor
Tianjin Medical University Second Hospital196 enrolled2 locationsNCT07187635
Recruiting

Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

Urothelial Carcinoma (UC)Bladder (Urothelial, Transitional Cell) CancerLiquid Biopsy
Tianjin Medical University Second Hospital300 enrolled1 locationNCT07441499
Recruiting
Phase 2

Topical GHK-Cu Gel for Acute Skin Wound Healing

Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds)
Hudson Biotech60 enrolled1 locationNCT07437586
Recruiting
Not Applicable

Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies

PainAnxietyBreast Biopsy
Jonsson Comprehensive Cancer Center600 enrolled1 locationNCT07310004
Recruiting

Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement

Sentinel Lymph Node Biopsy (SLNB)ALNDTargeted Axillary Dissection (TAD)
European Institute of Oncology150 enrolled14 locationsNCT07278726
Recruiting
Not Applicable

CT-guided Lung Biopsy Risk Optimization Method

PneumothoraxRisk FactorsRadiology, Interventional+1 more
Insel Gruppe AG, University Hospital Bern198 enrolled1 locationNCT06340178
Recruiting
Phase 3

No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant Chemotherapy

Breast CancerNeoadjuvant TherapySentinel Lymph Node Biopsy
Seoul National University Hospital464 enrolled1 locationNCT06704945
Recruiting
Not Applicable

Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)

Breast CancerMastectomySentinel Lymph Node Biopsy (SLNB)+7 more
Isabelle Henskens90 enrolled2 locationsNCT07362485